Insider · CIK 0002082879
Emmanuel Ligner
ceopresidentofficerdirector
Files at AVTR (Avantor, Inc.). First filing Nov 17, 2025, latest Nov 17, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$993k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AVTR: Avantor, Inc.
AVTROct 9, 2026 · close 15.67
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 74Notable | AVTRbuy Avantor, Inc. | $993k 87,500 shares | +45% | 0% from low-52% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | AVTR Avantor, Inc. | AGrant or award Common Stock | +483,713 | $0.00 | $0 | 767,137 | Feb 23, 2026 |
| Feb 19, 2026 | AVTR Avantor, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +1,903,847 | $0.00 | $0 | 1,903,847 | Feb 23, 2026 |
| Nov 17, 2025 | AVTR Avantor, Inc. | POpen-market purchase Common Stock | +87,500 | $11.35 | $993k | 283,424 | Nov 17, 2025 |
| Aug 18, 2025 | AVTR Avantor, Inc. | AGrant or award Common Stock | +195,924 | $0.00 | $0 | 195,924 | Aug 21, 2025 |
| Aug 18, 2025 | AVTR Avantor, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +573,394 | $0.00 | $0 | 573,394 | Aug 21, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.